Scarica l'app Stockscreener
191.92
1.20%
2.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$189.70
Aprire:
$189.67
Volume 24 ore:
2.08M
Relative Volume:
0.88
Capitalizzazione di mercato:
$40.57B
Reddito:
$447.02M
Utile/perdita netta:
$-1.18B
Rapporto P/E:
-31.05
EPS:
-6.1812
Flusso di cassa netto:
$-906.14M
1 W Prestazione:
+3.08%
1M Prestazione:
+18.26%
6M Prestazione:
+194.98%
1 anno Prestazione:
+161.04%
Intervallo 1D:
$185.69
$192.39
Intervallo di 1 settimana:
$182.09
$192.39
Portata 52W:
$60.40
$197.08
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-28 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
Trend analysis for Insmed Incorporated this weekJuly 2025 PostEarnings & Weekly High Return Opportunities - newser.com
How Insmed Incorporated (IM8N) stock compares with tech leadersPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsWeekly Profit Recap & Stock Market Timing Techniques - newser.com
Building trade automation scripts for Insmed IncorporatedMarket Growth Review & Verified Technical Trade Signals - newser.com
Will Insmed Incorporated stock benefit from automation2025 Top Gainers & Daily Price Action Insights - newser.com
Insmed's chief medical officer sells $2.97 million in stock - MSN
Why Insmed Incorporated is moving todayMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Historical volatility pattern of Insmed Incorporated visualizedWeekly Risk Summary & Daily Oversold Bounce Ideas - newser.com
Insmed Incorporated (NASDAQ:INSM) Q1 2025 Earnings Call Transcript - MSN
Is Insmed Incorporated (IM8N) stock a buy before new product rolloutProfit Target & Free Growth Oriented Trading Recommendations - newser.com
What dividend safety score for Insmed Incorporated stockPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com
Can Insmed Incorporated (IM8N) stock sustain institutional flows2025 AllTime Highs & Daily Oversold Stock Bounce Ideas - fcp.pa.gov.br
Will Insmed Incorporated (IM8N) stock see valuation expansionPortfolio Risk Summary & Verified Entry Point Signals - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulence2025 Macro Impact & Short-Term High Return Strategies - newser.com
Insmed Incorporated stock volume spike explained2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Why Insmed Incorporated stock could see breakout soon2025 Fundamental Recap & Precise Swing Trade Entry Alerts - fcp.pa.gov.br
Insider Buy: Will Insmed Incorporated stock outperform value stocks2025 Market Sentiment & Risk Managed Investment Strategies - Fundação Cultural do Pará
[Form 4] INSMED Inc Insider Trading Activity - Stock Titan
What insider trading reveals about Insmed Incorporated stock2025 Stock Rankings & Capital Efficiency Focused Ideas - fcp.pa.gov.br
Insmed (NASDAQ: INSM) to present at Jefferies Nov 18 and Evercore Dec 2; live webcasts - Stock Titan
Insmed, Inc. $INSM Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
What machine learning models say about Insmed IncorporatedTrade Analysis Report & Verified Swing Trading Watchlists - newser.com
Bryce Point Capital LLC Invests $583,000 in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Bought by Atria Investments Inc - MarketBeat
3,909 Shares in Insmed, Inc. $INSM Purchased by Corton Capital Inc. - MarketBeat
Can Insmed Incorporated stock deliver surprise earnings beatPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Assetmark Inc. Acquires 5,892 Shares of Insmed, Inc. $INSM - MarketBeat
Nisa Investment Advisors LLC Sells 1,556 Shares of Insmed, Inc. $INSM - MarketBeat
Latest read on first-in-disease therapy from Insmed CEO Will Lewis - MSN
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Insmed Inc Azioni (INSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Smith Michael Alexander | Chief Legal Officer |
Nov 03 '25 |
Sale |
183.78 |
27,130 |
4,985,911 |
54,902 |
2.88%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):